PLA2G7 and Alzheimer disease: Like Lp-PLA2 inhibitors, NCBV might be a novel therapeutic for Alzheimer’s disease because its supposed mechanism is the inhibition of nerve cell destruction, indicating a protective effect rather than just alleviating the symptoms.